Ray Co., Ltd. (228670.KQ)

KRW 7680.0

(3.09%)

Operating Expenses Summary of Ray Co., Ltd.

  • Ray Co., Ltd.'s latest annual operating expenses in 2023 was 59.03 Billion KRW , up 37.56% from previous year.
  • Ray Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 28.69 Billion KRW , up 111.31% from previous quarter.
  • Ray Co., Ltd. reported a annual operating expenses of 42.91 Billion KRW in annual operating expenses 2022, up 64.61% from previous year.
  • Ray Co., Ltd. reported a annual operating expenses of 26.07 Billion KRW in annual operating expenses 2021, up 31.15% from previous year.
  • Ray Co., Ltd. reported a quarterly operating expenses of 28.69 Billion KRW for 2024 Q2, up 111.31% from previous quarter.
  • Ray Co., Ltd. reported a quarterly operating expenses of 12.76 Billion KRW for 2023 Q3, down -18.56% from previous quarter.

Annual Operating Expenses Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Operating Expenses of Ray Co., Ltd. (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 59.03 Billion KRW 37.56%
2022 42.91 Billion KRW 64.61%
2021 26.07 Billion KRW 31.15%
2020 19.87 Billion KRW -3.23%
2019 20.54 Billion KRW 26.73%
2018 16.2 Billion KRW 26.99%
2017 12.76 Billion KRW 0.0%

Peer Operating Expenses Comparison of Ray Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Osang Healthcare Co.,Ltd 78.35 Billion KRW 24.664%
InBody Co.,Ltd 87.36 Billion KRW 32.43%
Curexo Inc. 18.16 Billion KRW -225.013%
Seegene, Inc. 210.08 Billion KRW 71.9%
i-SENS, Inc. 91.12 Billion KRW 35.221%
Gencurix Inc. 12.79 Billion KRW -361.258%
Sugentech Inc. 18.6 Billion KRW -217.318%
L&C Bio Co., Ltd 25.86 Billion KRW -128.27%